Dr. Indu Pal Kaur is a professor of Pharmaceutics and currently the Chairperson at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, India. Her research forte enhances the performance of drugs, including small and large biomolecules, viz. probiotics using active-tailored delivery systems. The emphasis of her work lies in Industrial and clinical translation, as evidenced by four technologies transferred by her group to the Industry. She has 145 high-impact publications, 21 book chapters, four books, and 4 Journal special issues to her credit. She is on the Editorial and Review Board of more than 50 journals. 
Dr. Parneet Kaur Deol is presently working as Assistant Professor at G.H.G. Khalsa College of Pharmacy Gurusar Sadhar Ludhiana, Punjab, India. She has more than ten years of experience in probiotic research and has published her work in highly reputed peer-reviewed international journals. She has co-edited a particular issue for ‘Current Pharmaceutical Design’ with Prof. Indu Pal Kaur in 2019. Dr. Deol has presented her work at various national and international platforms. She has contributed 21 international publications to her credit, with a cumulative impact of more than 50. 
Dr. Simarjot Kaur Sandhu is presently working as an analytical chemist at Taro Pharmaceutical Industries Ltd. Brampton, Ontario, Canada. She has done her doctorate from the Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India. Her area of research lies in improving the profile of phytopharmaceuticals and probiotics by encapsulating them within nanoparticles. She has published six international publications and has filed two India Patent Applications and one European and one US patent application out of her Ph.D. work.

Dr. Indu Pal Kaur is a professor of Pharmaceutics and currently the Chairperson at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, India. Her research forte enhances the performance of drugs, including small and large biomolecules, viz. probiotics using active-tailored delivery systems. The emphasis of her work lies in Industrial and clinical translation, as evidenced by four technologies transferred by her group to the Industry. She has 145 high-impact publications, 21 book chapters, four books, and 4 Journal special issues to her credit. She is on the Editorial and Review Board of more than 50 journals. 
Dr. Parneet Kaur Deol is presently working as Assistant Professor at G.H.G. Khalsa College of Pharmacy Gurusar Sadhar Ludhiana, Punjab, India. She has more than ten years of experience in probiotic research and has published her work in highly reputed peer-reviewed international journals. She has co-edited a particular issue for ‘Current Pharmaceutical Design’ with Prof. Indu Pal Kaur in 2019. Dr. Deol has presented her work at various national and international platforms. She has contributed 21 international publications to her credit, with a cumulative impact of more than 50. 
Dr. Simarjot Kaur Sandhu is presently working as an analytical chemist at Taro Pharmaceutical Industries Ltd. Brampton, Ontario, Canada. She has done her doctorate from the Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India. Her area of research lies in improving the profile of phytopharmaceuticals and probiotics by encapsulating them within nanoparticles. She has published six international publications and has filed two India Patent Applications and one European and one US patent application out of her Ph.D. work.